StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) company profile

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

About Elevance Health

Hospital & Medical Service Plans, SIC 6324

Elevance Health delivers integrated health solutions spanning medical, pharmacy, and behavioral health services. The enterprise operates across four primary segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. Product offerings include risk-based network plans like PPOs and HMOs, fee-based administrative solutions, pharmacy management, and specialty options such as dental, vision, stop loss, and supplemental coverage. Customers include individual consumers, small and large employer groups, and participants in federal and state-sponsored Medicare and Medicaid programs.

The organization serves approximately 45.2 million medical members across the United States through its affiliated health plans as of December 31, 2025. It holds Blue Cross and Blue Shield licenses covering fourteen individual states and operates non-BCBS brands like Wellpoint, MMM, and Simply Healthcare across multiple regions. Subsidiaries maintain insurance operating licenses in all fifty states, the District of Columbia, and Puerto Rico. The company's headquarters location is not specified in the provided business disclosure text.

Summary of the business section of Elevance Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Elevance Health, Inc.
Founded
1940
Headquarters
Indianapolis, IN
Address
220 Virginia Avenue 46204
Phone
(800) 331-1476
Employees
97,100, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Indiana
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Indianapolis, Indiana

Stock & identifiers

Ticker
ELV
Former tickers
ANTM until Jun 28, 2022; WLP until Feb 24, 2015
Exchange
NYSE
IPO date
Oct 30, 2001
Shares outstanding
216M, Oct 15, 2026
Public float
$87.35B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jun 1, 2005
SEC CIK
1156039
CUSIP
036752103
ISIN
US0367521038
FIGI
BBG000BCG930
Share class FIGI
BBG001S6KBQ8
LEI
8MYN82XMYQH89CTMTH67
EIN
35-2145715

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Gail BoudreauxPresident and CEO, Director172,036
Ratnakar LavuEVP & Chief Digital Info Ofr14,849
Mark KayeEVP & CFO19,919
Erin M. WesslingEVP & Chief Legal Officer7,230
Ryan R. CraigEVP & Chief HR Officer6,530
Ronald W. PenczekCAO & Controller3,740
Charles Morgan Kendrick JREVP & President, Commercial11,791
Peter D. HaytaianEVP & Pres Carelon & CarelonRx27,222
Felicia F. NorwoodEVP &Chief Health Benefits Ofr38,838
Blair Williams TodtEVP, CLO & CAO15,631
Ramiro G. PeruDirector10,908
Robert L. Dixon JRDirector10,734
Amy W. SchulmanDirector781
Antonio F. NeriDirector5,488
Ryan M. SchneiderDirector7,163
Lewis Hay IiiDirector12,070
Steven H. CollisDirector4,202
Deanna D. Strable-SoethoutDirector2,209
Susan D. DeVoreDirector4,065
Bahija JallalDirector5,351
R. Kerry ClarkDirector9,640

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$22.58M$18.79M$7.21M$117$148
FY2024$20.47M-$3.96M$6.33M$121$129
FY2023$21.89M$16.22M$8.92M$152$126
FY2022$20.93M$35.26M$6.71M$163$124
FY2021$19.35M$50.43M$6.45M$146$126
FY2020$17.11M$28.32M$5.39M$108$113

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Gail Boudreaux
President and Chief Executive Officer (CEO)
$1.60M$13.44M$4.20M$2.77M$574.27K$22.58M+10%
Mark Kaye
EVP and Chief Financial Officer (CFO)
$938.46K$4.56M$1.42M$974.12K$94.48K$7.99M+16%
Peter Haytaian
EVP and President, Carelon and CarelonRx
$950.00K$3.84M$1.20M$986.10K$122.37K$7.10M+12%
Felicia Norwood
EVP and Chief Health Benefits Officer
$950.00K$3.84M$1.20M$986.10K$97.85K$7.07M+12%
Morgan Kendrick
EVP and President, Commercial and Specialty Health Benefits
$888.46K$3.60M$1.12M$922.22K$126.18K$6.66M+15%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, our employee population, including all full-time, part-time and temporary workers, consisted of approximately 97,100 individuals, 71,900 in the United States and 25,200 internationally.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jun 24, 2022Name changeName changed from Anthem, Inc. to Elevance Health, Inc.
Apr 20, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 1, 2018DelistingNotice of delisting from exchange (Form 25)
Oct 1, 2015MergerRegistration of securities for a merger or exchange offer (S-4)
May 8, 2015ListingRegistration of securities on an exchange (Form 8-A)
Nov 12, 2014Name changeName changed from WELLPOINT, INC to Anthem, Inc.
Dec 1, 2009Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 5, 2006DeregistrationTermination of SEC registration (Form 15)
Dec 28, 2005DeregistrationTermination of SEC registration (Form 15)
Dec 28, 2005Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 27, 2005MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 9, 2005MergerRegistration of securities for a merger or exchange offer (S-4)
Nov 30, 2004Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 30, 2004Name changeName changed from ANTHEM INC to WELLPOINT INC
Nov 18, 2004DelistingNotice of delisting from exchange (Form 25)
Feb 23, 2004DeregistrationTermination of SEC registration (Form 15)
Nov 26, 2003MergerRegistration of securities for a merger or exchange offer (S-4)
May 21, 2002MergerRegistration of securities for a merger or exchange offer (S-4)
Oct 30, 2001IPOInitial public offering priced (424B4 prospectus)
Oct 26, 2001ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?